This year’s FDA approval of the iLet Insulin Bionic Pancreas followed a 13-week randomized clinical trial conducted in San Antonio.
This year’s FDA approval of the iLet Insulin Bionic Pancreas followed a 13-week randomized clinical trial conducted in San Antonio.
Sign up for the Daily Reach to get essential San Antonio news in your inbox every morning.
Sign up for The Recap to get the most important San Antonio news in your inbox twice a week.
